Cortecs International appoints Dr. Martin Preuveneers as international operations director.LONDON, England--(BUSINESS WIRE)--Oct. 8, 1996--Cortecs International (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :DLVRY / LSE LSE - Language Sensitive Editor :COR / ASX ASX See: Australian Stock Exchange :CRI CRI constant-rate infusion. ) today announced the appointment of Dr. Martin Preuveneers to the position of International Operations Director. Dr. Preuveneers has extensive international experience in the health care industry in the areas of pharmaceutics, medical diagnostics and biotechnology. Dr. Preuveneers is also currently on the Board of the U.K. BioIndustry Association (BIA BIA abbr. Bureau of Indian Affairs ). Previously, he was Chief Executive Officer of Therexsys Limited, a biotechnology company, and spent 13 years at GlaxoWellcome in senior international marketing and business development positions. Commenting on the appointment, Glen Travers, Executive Chairman of Cortecs, said: "We are very pleased to welcome Dr. Preuveneers to Cortecs where his considerable commercial and strategic experience will make an important contribution to the Company's development. Cortecs is now entering into a phase with its therapeutics for the oral delivery of peptides and vaccines where the preparation and international commercialization of these products requires the experience that Martin brings to us. We are continuing to build a team with world class skills in marketing to fully realize the potential of these products." Cortecs is a British-based company quoted on the London Stock Exchange London Stock Exchange London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses. , the Australian Stock Exchange Australian Stock Exchange (ASX) Australia's major securities market, formed when the six state stock exchanges (Adelaide, Brisbane, Hobart, Melbourne, Perth, and Sydney stock exchanges) were merged in 1987. and on NASDAQ. The Company specializes in the development of new pharmaceutical delivery systems and point-of-care rapid diagnostics which provide the opportunity to advance the management of serious diseases. NOTE: Press releases and other Cortecs International Limited information are available on the Cortecs International Limited web site: http://www.cortecs.com. CONTACT: Glen Travers, Executive Chairman or Dr. Michael Flynn, President Cortecs International 011 44 181 568 7071 or Zena Bates Buchanan Communications 011 44 171 489 1441 or John P. Kehoe/Van Negris Kehoe, White, Savage & Company, Inc. (212) 888-1616 |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion